SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-006147
Filing Date
2018-08-02
Accepted
2018-08-02 06:16:56
Documents
60
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tbph-20180630x10q.htm 10-Q 1973939
2 EX-10.1 tbph-20180630ex101ec4270.htm EX-10.1 45953
3 EX-10.2 tbph-20180630ex10293d232.htm EX-10.2 280197
4 EX-10.3 tbph-20180630ex1036aa376.htm EX-10.3 477152
5 EX-31.1 tbph-20180630ex3115118e3.htm EX-31.1 14940
6 EX-31.2 tbph-20180630ex3126054c0.htm EX-31.2 14942
7 EX-32 tbph-20180630xex32.htm EX-32 17297
8 GRAPHIC tbph20180630ex101ec4270001.jpg GRAPHIC 761258
9 GRAPHIC tbph20180630ex10293d232001.jpg GRAPHIC 4454
10 GRAPHIC tbph20180630ex1036aa376001.jpg GRAPHIC 4454
  Complete submission text file 0001558370-18-006147.txt   7547663

Data Files

Seq Description Document Type Size
11 EX-101.INS tbph-20180630.xml EX-101.INS 1090710
12 EX-101.SCH tbph-20180630.xsd EX-101.SCH 36588
13 EX-101.CAL tbph-20180630_cal.xml EX-101.CAL 42973
14 EX-101.DEF tbph-20180630_def.xml EX-101.DEF 121984
15 EX-101.LAB tbph-20180630_lab.xml EX-101.LAB 319405
16 EX-101.PRE tbph-20180630_pre.xml EX-101.PRE 236489
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36033 | Film No.: 18986522
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1